274 related articles for article (PubMed ID: 15326291)
1. Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1alpha,25(OH)2-vitamin D3 signaling.
Mizwicki MT; Keidel D; Bula CM; Bishop JE; Zanello LP; Wurtz JM; Moras D; Norman AW
Proc Natl Acad Sci U S A; 2004 Aug; 101(35):12876-81. PubMed ID: 15326291
[TBL] [Abstract][Full Text] [Related]
2. Applications of the Vitamin D sterol-Vitamin D receptor (VDR) conformational ensemble model.
Mizwicki MT; Bishop JE; Norman AW
Steroids; 2005; 70(5-7):464-71. PubMed ID: 15862832
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms.
Haussler MR; Jurutka PW; Mizwicki M; Norman AW
Best Pract Res Clin Endocrinol Metab; 2011 Aug; 25(4):543-59. PubMed ID: 21872797
[TBL] [Abstract][Full Text] [Related]
4. A perspective on how the Vitamin D sterol/Vitamin D receptor (VDR) conformational ensemble model can potentially be used to understand the structure-function results of A-ring modified Vitamin D sterols.
Mizwicki MT; Bula CM; Bishop JE; Norman AW
J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):69-82. PubMed ID: 16055325
[TBL] [Abstract][Full Text] [Related]
5. 25-Dehydro-1alpha-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change.
Bula CM; Bishop JE; Ishizuka S; Norman AW
Mol Endocrinol; 2000 Nov; 14(11):1788-96. PubMed ID: 11075812
[TBL] [Abstract][Full Text] [Related]
6. Minireview: vitamin D receptor: new assignments for an already busy receptor.
Norman AW
Endocrinology; 2006 Dec; 147(12):5542-8. PubMed ID: 16946007
[TBL] [Abstract][Full Text] [Related]
7. The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response signaling.
Mizwicki MT; Norman AW
Sci Signal; 2009 Jun; 2(75):re4. PubMed ID: 19531804
[TBL] [Abstract][Full Text] [Related]
8. New insights into Vitamin D sterol-VDR proteolysis, allostery, structure-function from the perspective of a conformational ensemble model.
Mizwicki MT; Bula CM; Bishop JE; Norman AW
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):243-62. PubMed ID: 17368177
[TBL] [Abstract][Full Text] [Related]
9. The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha,25(OH)2-vitamin D3 in vivo and in vitro.
Huhtakangas JA; Olivera CJ; Bishop JE; Zanello LP; Norman AW
Mol Endocrinol; 2004 Nov; 18(11):2660-71. PubMed ID: 15272054
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D receptor signaling and its therapeutic implications: Genome-wide and structural view.
Carlberg C; Molnár F
Can J Physiol Pharmacol; 2015 May; 93(5):311-8. PubMed ID: 25741777
[TBL] [Abstract][Full Text] [Related]
11. 1alpha,25(OH)2-Vitamin D3 stimulation of secretion via chloride channel activation in Sertoli cells.
Menegaz D; Barrientos-Duran A; Kline A; Silva FR; Norman AW; Mizwicki MT; Zanello LP
J Steroid Biochem Mol Biol; 2010 Apr; 119(3-5):127-34. PubMed ID: 20156558
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling, affinity labeling, and site-directed mutagenesis define the key points of interaction between the ligand-binding domain of the vitamin D nuclear receptor and 1 alpha,25-dihydroxyvitamin D3.
Swamy N; Xu W; Paz N; Hsieh JC; Haussler MR; Maalouf GJ; Mohr SC; Ray R
Biochemistry; 2000 Oct; 39(40):12162-71. PubMed ID: 11015194
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor (VDR) regulation of voltage-gated chloride channels by ligands preferring a VDR-alternative pocket (VDR-AP).
Menegaz D; Mizwicki MT; Barrientos-Duran A; Chen N; Henry HL; Norman AW
Mol Endocrinol; 2011 Aug; 25(8):1289-300. PubMed ID: 21659475
[TBL] [Abstract][Full Text] [Related]
14. Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor.
Väisänen S; Peräkylä M; Kärkkäinen JI; Uskokovic MR; Carlberg C
Mol Pharmacol; 2003 Jun; 63(6):1230-7. PubMed ID: 12761332
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of the selective activity of vitamin D analogues.
Carlberg C
J Cell Biochem; 2003 Feb; 88(2):274-81. PubMed ID: 12520526
[TBL] [Abstract][Full Text] [Related]
16. Ligand recognition by the vitamin D receptor.
Choi M; Yamamoto K; Masuno H; Nakashima K; Taga T; Yamada S
Bioorg Med Chem; 2001 Jul; 9(7):1721-30. PubMed ID: 11425573
[TBL] [Abstract][Full Text] [Related]
17. Fine tuning of agonistic/antagonistic activity for vitamin D receptor by 22-alkyl chain length of ligands: 22S-Hexyl compound unexpectedly restored agonistic activity.
Anami Y; Sakamaki Y; Itoh T; Inaba Y; Nakabayashi M; Ikura T; Ito N; Yamamoto K
Bioorg Med Chem; 2015 Nov; 23(22):7274-81. PubMed ID: 26515040
[TBL] [Abstract][Full Text] [Related]
18. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
Harant H; Spinner D; Reddy GS; Lindley IJ
J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
[TBL] [Abstract][Full Text] [Related]
19. Structural Studies of Vitamin D Nuclear Receptor Ligand-Binding Properties.
Belorusova AY; Rochel N
Vitam Horm; 2016; 100():83-116. PubMed ID: 26827949
[TBL] [Abstract][Full Text] [Related]
20. Hereditary 1,25-dihydroxyvitamin D resistant rickets due to a mutation causing multiple defects in vitamin D receptor function.
Malloy PJ; Xu R; Peng L; Peleg S; Al-Ashwal A; Feldman D
Endocrinology; 2004 Nov; 145(11):5106-14. PubMed ID: 15308610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
